Legal News

Rabson new partner at Wilson Sonsini

By Richard Binder

Wilson Sonsini Goodrich & Rosati announced today that Michael Rabson has rejoined the firm as a partner. He will be based in the firm's Palo Alto office and serve as a strategic advisor to life sciences and clean technology clients.

Prior to joining the firm, Rabson served as general counsel and senior vice president for business development and legal affairs at Cytokinetics, a clinical-stage biopharmaceutical company focused on the development of small-molecule therapeutics. Previously, he was general counsel and senior vice president at Maxygen, an international biotechnology company devoted to the production of improved protein drugs. Before his tenure at Maxygen, Rabson was a partner at Wilson Sonsini Goodrich & Rosati, where his practice focused on life sciences, including therapeutics, agriculture, and medical devices, as well as material sciences. Earlier in his career, he was a patent examiner specializing in biotechnology and genetic engineering at the U.S. Patent and Trademark Office.

Rabson received his J.D. from Yale Law School in 1989, earned a Ph.D. in infectious disease epidemiology from Yale University in 1983, and was a postdoctoral fellow at the National Cancer Institute at the National Institutes of Health. He received a B.S. in biological studies from Cornell University in 1975.

Full story here.

Full post as published by Legal Pad | LA on March 10, 2010 (boomark / email).